Lonza opens world’s largest cell-and-gene-therapy manufacturing facility in USA

2018-04-11 08:51:57

This is considered to be a first-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases. By Team ABLEGlobally recognized biopharma company Lonza has opened its largest dedicated cell-and-gene-therapy facility, which was built in anticipation of the rising demand from develo

Read more

2018-04-11 08:51:05

AIIMS professor Balram Bhargava appointed as DG of ICMRBharagava, at present Professor/Senior Consultant Cardiologist at All India Institute of Medical Sciences (AIIMS) here, has been appointed to the post for a period of three yearsBy Team ABLEAIIMS professor Balram Bhargava was appointed the Director General of Indian Council of Medical Research (ICMR) and Secretary of the Department of Health R

Read more

BIRAC Managing Director Dr Renu Swarup to be India’s new DBT Secretary

2018-04-10 10:36:00

Dr Renu Swarup has been appointed as India’s sixth DBT Secretary. She is the second woman after Dr Manju Sharma to hold the prestigious post.By Team ABLEDr Renu Swarup will be the next DBT (Department of Biotechnology) Secretary. She succeeds Prof. K VijayRaghavan, who was secretary of DBT from January 2013 handed over the charge on February 05, 2018. Prof. VijayRaghavan is now the principal sci

Read more

IIT Ropar proposes Active Infrared Thermography application method for early breast cancer diagnosis

2018-04-10 09:13:04

IIT Ropar scientists are working towards the development of portable, low cost, an \nactive infrared screening system, which will provide an early detection \nof breast cancer.By Team ABLEThe Indian Institute of Technology Ropar has introduced a novel pulse compression favourable Active Infrared Thermography for early detection of breast cancer in women of all ages, including pregnant or nursing w

Read more

Novartis expands gene therapy business with AveXis acquisition for $USD 8.7 bn

2018-04-10 09:10:05

AveXis lead product candidate, AVXS-101, has potential to be first-ever one-time gene replacement therapy for spinal muscular atrophy (SMA), a disease which results in early death or lifelong disability with considerable healthcare costsBy Team ABLENovartis has entered into an agreement and plan of merger with AveXis, to acquire the US-based Nasdaq-listed clinical stage gene therapy company f

Read more

Merck Foundation calls for Application for Merck Hypertension and Diabetes Awards 2018

2018-04-10 09:08:54

Merck Foundation has announced the call for application for Merck Diabetes and Hypertension awards 2018, across the African and Asian Universities through its Merck Capacity Advancement Program.By Team ABLEMerck Foundation, the Philanthropic arm of Merck KGaA Germany, has announced the call for application for Merck Diabetes and Hypertension awards 2018, across the African and Asian Universities t

Read more

Bharat Biotech unveils new brand identity; Donates Rs 1 crore worth vaccines to celebrate 20 Years of ‘Leading Innovation’

2018-04-09 23:32:36

Over the last 20 years Bharat Biotech has a built a strong portfolio of more than 50 patents, 20+ commercially available safe, affordable and best in class vaccines and bio therapeutic products, accessible in over 100 countries.By Team ABLE Genome Valley based \"Clone-to-Clinic\" Indian biotechnology MNC, Bharat Biotech, unveiled its new corporate logo and its vision for the future. With its new l

Read more

Novo Nordisk get exclusive worldwide licence to EpiDestiny\'s sickle cell disease programme

2018-04-09 23:25:32

Novo Nordisk secures blood drug licence to boost anaemic biopharma businessBy Team ABLENovo Nordisk and EpiDestiny announced that Novo Nordisk has obtained an exclusive worldwide licence to EpiDestiny\'s sickle cell disease (SCD) programme, EPI01.EpiDestiny is eligible to receive more than 400 million US dollars in upfront, development and sales milestone payments and will get royalties on net sal

Read more

Biopharma caught in the crosshairs of US-China trade tussle

2018-04-09 23:24:04

Just a week after Johnson & Johnson chief Alex Gorsky and Novartis CEO Vasant Narasimhan expressed longing for stable and fair trade, biopharmaceuticals and medical devices have been dragged into the $100 billion trade war between the U.S. and China, the world’s two largest economies.Source: https://www.fiercepharma.com/pharma/despite-industry-wishes-biopharmaceuticals-caught-crosshairs-u-s-

Read more

BIO Announces Keynote and Returns to Boston June 4-7 to Celebrate 25 Years of History-Making Innovation

2018-04-09 23:08:46

The BIO International Convention will return to the Boston Convention & Exhibition Center, June 4-7, to celebrate 25 years of advocacy and innovation. By Team ABLEHosted by the Biotechnology Innovation Organization (BIO), the 2018 event is expected to attract more than 16,000 attendees and 1,800 exhibitors from 74 countries – all who will be welcomed in a special, keynote address by ABC’s

Read more